- ►annals.org [PDF] T McLaughlin, F Abbasi, K Cheal, J Chu, C … - Annals of internal medicine, 2003 - Am Coll Physicians Background: Insulin resistance is more common in overweight individuals and is
associated with increased risk for type 2 diabe- tes mellitus and cardiovascular
disease. Given the current epi- demic of obesity and the fact that ... Cited by 301 - Related articles - BL Direct - All 5 versions
- ►ajcn.org S Liu, WC Willett, JAE Manson, FB Hu, B … - American Journal of Clinical Nutrition, 2003 - Am Soc Nutrition 2 Supported by National Institutes of Health grant CA87969 and by Clinical
Scientist Development Award K08-DK 02767 from the National Institute of Diabetes
and Digestive and Kidney Diseases (to SL). In addition, for activities ... Cited by 231 - Related articles - BL Direct - All 7 versions
G Reaven, F Abbasi, T McLaughlin - Recent Progress in Hormone Research, 2004 - Endocrine Soc The ability of insulin to stimulate glucose disposal varies more than six-fold
in apparently healthy individuals. The one third of the population that is most
insulin resistant is at greatly increased risk to develop cardiovascular ... Cited by 126 - Related articles - BL Direct - All 2 versions
JD Douketis, C Macie, L Thabane, DF … - International Journal of Obesity, 2005 - nature.com Dietary/lifestyle therapy provides <5 kg weight loss after 2–4 y,
pharmacologic therapy provides 5–10 kg weight loss after 1–2 y, and surgical
therapy provides 25–75 kg weight loss after 2–4 y. Weight loss of 5% ... Cited by 105 - Related articles - BL Direct - All 5 versions
J Kruger, DA Galuska, MK Serdula, DA Jones - American journal of preventive medicine, 2004 - Elsevier Twenty-four percent of men and 38% of women were trying to lose weight.
Attempting weight loss was less common among normal weight (body mass index
[BMI]<25 kg/m 2 ) people (6% men, 24% women) than overweight (BMI≥25 to ... Cited by 78 - Related articles - All 14 versions
RS Stafford, DC Radley - Archives of Internal Medicine, 2003 - Am Med Assoc Results At its peak in the second quarter of 1997, 2.5 million Americans were
taking antiobesity medications, a 4-fold increase over the prior 2 years.
Although antiobesity medication use diminished following the market exit of ... Cited by 59 - Related articles - BL Direct - All 5 versions
- ►bmj.com D Arterburn, PH Noel - British Medical Journal, 2001 - bmj.com You are seeing this message because your web browser does not support basic web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... David Arterburn , chief ... Cited by 51 - Related articles - BL Direct - All 7 versions
A Hyduk, JB Croft, C Ayala, K Zheng, ZJ … - MMWR Surveill Summ, 2005 - cdc.gov Description of Systems: This report summarizes mortality data from the National
Vital Statistic System (NVSS) and hospital discharge data from the National
Hospital Discharge Survey (NHDS) for 1980--2002 and Medicare hospital ... Cited by 44 - Related articles - Cached - All 4 versions
- ►smh.com [PDF] JR Berger - Archives of Neurology, 2004 - Am Med Assoc Weight is a national obsession. In 1999, Americans spent more than $300 million
on prescription medications for obesity, 1 and 2.5% of the adult population
reported using such preparations at the end of the 20th century. 2 By some ... Cited by 42 - Related articles - BL Direct - All 5 versions
G Dubnov, A Brzezinski, EM Berry - Maturitas, 2003 - Elsevier Background: Postmenopausal women have an increased tendency for gaining weight.
The declines of endogenous estrogen, together with physical inactivity, are
probably the major causes of this phenomenon. Postmenopausal overweight and ... Cited by 35 - Related articles - All 13 versions
